Ocrevus now approved by NICE for PPMS
https://www.mstrust.org.uk/news/good-news-nice-approves-ocrevus-ocrelizumab-primary-progressive-ms
Today's announcement.
The MS Trust is delighted that Ocrevus (ocrelizumab) has been approved by NICE for NHS treatment of early, inflammatory primary progressive MS.
NICE has approved Ocrevus for people with primary progressive MS if they:
have had symptoms of primary progressive MS for 15 years or less
and
are able to walk 20 metres or more, with or without walking aids (up to EDSS 6.5)
and
have evidence of MS activity on MRI scans.
As someone who has just been diagnosed with PPMS I'm rather encouraged by this. Any views on its effectiveness would be appreciated!
Hi @cathie16, scroll down for earlier posts today, especially from @dominics